Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Other financing activities (2024)

Historic Other financing activities for Foghorn Therapeutics (FHTX) over the last 1 years, with Q3 2024 value amounting to $390000.0.

  • Foghorn Therapeutics' Other financing activities changed N/A to $390000.0 in Q3 2024 from the same period last year, while for Sep 2025 it was $390000.0, marking a year-over-year change of. This contributed to the annual value of $585000.0 for FY2024, which is N/A changed from last year.
  • Per Foghorn Therapeutics' latest filing, its Other financing activities stood at $390000.0 for Q3 2024.
  • In the past 5 years, Foghorn Therapeutics' Other financing activities registered a high of $390000.0 during Q3 2024, and its lowest value of $390000.0 during Q3 2024.